Alyeska Investment Group
MRVI icon

Alyeska Investment Group’s Maravai LifeSciences MRVI Stock Holding History

Alyeska Investment Group’s Portfolio MRVI Stock Details MRVI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-5,329,420
Closed -$29M – 610
2024
Q4 		$29M Buy
5,329,420
+3,161,072
+146% +$20.3M 0.11% 219
2024
Q3 		$18M Buy
2,168,348
+4,465
+0.2% +$38.6K 0.09% 244
2024
Q2 		$15.5M Buy
2,163,883
+27,394
+1% +$236K 0.09% 236
2024
Q1 		$18.5M Sell
2,136,489
-1,060,000
-33% -$7.17M 0.11% 219
2023
Q4 		$20.9M Buy
3,196,489
+810,742
+34% +$5.24M 0.14% 197
2023
Q3 		$23.9M Sell
2,385,747
-90,000
-4% -$988K 0.16% 183
2023
Q2 		$30.8M Buy
2,475,747
+691,686
+39% +$9.34M 0.23% 144
2023
Q1 		$25M Buy
1,784,061
+535,242
+43% +$7.69M 0.22% 136
2022
Q4 		$17.9M Sell
1,248,819
-360,753
-22% -$5.68M 0.18% 161
2022
Q3 		$41.1M Buy
1,609,572
+586,041
+57% +$14.7M 0.48% 70
2022
Q2 		$29.1M Buy
1,023,531
+147,384
+17% +$4.67M 0.33% 96
2022
Q1 		$30.9M Buy
+876,147
New +$29.4M 0.34% 102
2021
Q4 		– Sell
-440,046
Closed -$21.6M – 688
2021
Q3 		$21.6M Buy
+440,046
New +$21.5M 0.27% 109
2021
Q2 		– Sell
-123,764
Closed -$4.41M – 797
2021
Q1 		$4.41M Sell
123,764
-936,644
-88% -$31M 0.06% 349
2020
Q4 		$29.7M Buy
+1,060,408
New +$29.5M 0.42% 69

Other funds holding MRVI

GL
GTCR LLC Chicago, Illinois $3.78B AUM 27.82% 1-Year Est. Return
1WCM
12 West Capital Management New York $592M AUM 40.75% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
MFS
Mirabella Financial Services London, United Kingdom $1.06B AUM 19.83% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Alyeska Investment Group's MRVI Position: Q1 2025 in Review

Alyeska Investment Group sold out of Maravai LifeSciences (MRVI) in Q1 2025, closing a stake of 5,329,420 shares — an estimated $29M sold.

Alyeska Investment Group first reported a position in MRVI in Q4 2020 and held it in 15 quarters. The position peaked at $41.1M in Q3 2022. 184 funds tracked by Wall St. Rank hold MRVI as of Q1 2025.

  • Alyeska Investment Group reported no remaining Maravai LifeSciences position as of Q1 2025 after selling out during the quarter.
  • Alyeska Investment Group sold 5,329,420 Maravai LifeSciences shares in Q1 2025, an estimated $29M.
  • Alyeska Investment Group first reported a position in Maravai LifeSciences in Q4 2020 and held it in 15 quarters.
  • Alyeska Investment Group's Maravai LifeSciences position peaked at $41.1M in Q3 2022.
  • 184 funds tracked by Wall St. Rank held Maravai LifeSciences as of Q1 2025.

Based on Alyeska Investment Group's 13F filing for Q1 2025, filed 15 May 2025.